Durect Corp DRRX

NAS: DRRX | ISIN: US2666051048 6/08/2025

1,860 USD (+0,54%)

(+0,54%) 6/08/2025

Grafiek Durect Corp

Grafiek Durect Corp

1 dag1d 0,54%
1 week1w -0,53%
1 maand1m 190,62%
3 maanden3m 219,59%
6 maanden6m 144,74%
1 jaar1j 41,98%
5 jaar5j -20,17%

Durect Corp in het nieuws

Toon enkel gratis nieuws

13 mei 2025 · DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update · Persbericht

26 maart 2025 · DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update · Persbericht

19 maart 2025 · DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update · Persbericht

4 september 2024 · DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference · Persbericht

13 augustus 2024 · DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update · Persbericht

7 augustus 2024 · DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update · Persbericht

21 mei 2024 · DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis · Persbericht

13 mei 2024 · DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update · Persbericht

7 mei 2024 · DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update · Persbericht

30 april 2024 · DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis · Persbericht

Profiel Durect Corp

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.durect.com

Hoofdzetel: Cupertino, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe